The University of Alabama at Birmingham (UAB) received a $1,500,000 Cooperative Agreement award from the National Center for Chronic Disease Prevention and Health Promotion, part of the Centers for Disease Control and Prevention (CDC). The award supports UAB's project under the CDC's Centers for Research and Demonstration for Health Promotion and Disease Prevention program (CFDA 93.135) to implement an AI-based glaucoma screening program within Federally Qualified Health Centers. The five-year project aims to develop, test, and evaluate the use of AI technologies to enhance glaucoma screening and early detection, with the goal of improving vision health outcomes in underserved communities. As a leading research institution, UAB will leverage its expertise in biomedical engineering, data analytics, and healthcare delivery to advance this public health initiative.
Generated 3/4/25, 7:01 AM